Merck Plows Ahead With Another Suit Over Diabetes Drug
Merck has filed a lawsuit in Delaware federal court seeking to block Indian drugmaker Ajanta Pharma from moving ahead with plans to sell a generic version of a diabetes drug that...To view the full article, register now.
Already a subscriber? Click here to view full article